Jake Chernicky
@jakechernicky.bsky.social
2nd year Neuroscience PhD student in the Gratton Lab at the University of Illinois at Urbana-Champaign 🧠🌽
11/12
🧠 Bottom line:
Precision RSFC is feasible, reliable, and clinically promising in Parkinson’s disease.
This approach could explain the huge variation we see across individuals—and help us treat each person more effectively.
🧠 Bottom line:
Precision RSFC is feasible, reliable, and clinically promising in Parkinson’s disease.
This approach could explain the huge variation we see across individuals—and help us treat each person more effectively.
July 9, 2025 at 4:42 PM
11/12
🧠 Bottom line:
Precision RSFC is feasible, reliable, and clinically promising in Parkinson’s disease.
This approach could explain the huge variation we see across individuals—and help us treat each person more effectively.
🧠 Bottom line:
Precision RSFC is feasible, reliable, and clinically promising in Parkinson’s disease.
This approach could explain the huge variation we see across individuals—and help us treat each person more effectively.